Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Income from Continuing Operations (2020 - 2025)

Historic Income from Continuing Operations for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Q3 2025 value amounting to -$11.0 million.

  • Insight Molecular Diagnostics' Income from Continuing Operations rose 1825.38% to -$11.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$61.3 million, marking a year-over-year decrease of 4110.23%. This contributed to the annual value of -$61.0 million for FY2024, which is 14284.29% down from last year.
  • Per Insight Molecular Diagnostics' latest filing, its Income from Continuing Operations stood at -$11.0 million for Q3 2025, which was up 1825.38% from -$9.8 million recorded in Q2 2025.
  • Over the past 5 years, Insight Molecular Diagnostics' Income from Continuing Operations peaked at $6.0 million during Q1 2023, and registered a low of -$35.7 million during Q4 2021.
  • Moreover, its 5-year median value for Income from Continuing Operations was -$9.8 million (2025), whereas its average is -$10.9 million.
  • Over the last 5 years, Insight Molecular Diagnostics' Income from Continuing Operations had its largest YoY gain of 15790.5% in 2023, and its largest YoY loss of 51092.38% in 2023.
  • Insight Molecular Diagnostics' Income from Continuing Operations (Quarter) stood at -$35.7 million in 2021, then skyrocketed by 66.33% to -$12.0 million in 2022, then tumbled by 34.63% to -$16.2 million in 2023, then plummeted by 107.84% to -$33.6 million in 2024, then surged by 67.15% to -$11.0 million in 2025.
  • Its Income from Continuing Operations stands at -$11.0 million for Q3 2025, versus -$9.8 million for Q2 2025 and -$6.8 million for Q1 2025.